Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
Status:
Completed
Trial end date:
2021-06-12
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of melatonin 4 mg on circadian rhythm and visual function of
patients with diabetes mellitus. Half of the patients will receive melatonin (arm-1) and the
other half will receive placebo (arm-2), both groups in 3 weeks. After a week of washout, the
patients will cross over to the other treatment arm.
Phase:
Phase 3
Details
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Collaborators:
Steno Diabetes Center Steno Diabetes Center Copenhagen